Nanobody-Based Anti-CD5 CAR-T

anti-CD5 CAR-T cell therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nanobody-Based Anti-CD5 CAR-T, covering 2025-03-13 to 2025-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/LBL [Phase 1, Phase 2]